{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:19:24Z","timestamp":1761664764189,"version":"build-2065373602"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.patol.2019.08.001","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T01:20:49Z","timestamp":1574385649000},"page":"88-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Una visi\u00f3n integral del c\u00e1ncer (III). Evaluaci\u00f3n de nuevos biomarcadores y posibilidades de intervenci\u00f3n"],"prefix":"10.1016","volume":"53","author":[{"given":"Rosa","family":"Noguera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Burgos-Panadero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Lucantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"de la Cruz-Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"\u00c1lvaro Naranjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patol.2019.08.001_bib0445","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1158\/0008-5472.CAN-06-0040","article-title":"Cancers as wounds that do not heal: Differences and similarities between renal regeneration\/repair and renal cell carcinoma","volume":"66","author":"Riss","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.patol.2019.08.001_bib0450","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet."},{"key":"10.1016\/j.patol.2019.08.001_bib0455","first-page":"92","article-title":"Una visi\u00f3n integral del c\u00e1ncer (I). Microambiente tumoral: estudio, clasificaci\u00f3n y reprogramaci\u00f3n","volume":"52","author":"Noguera","year":"2019","journal-title":"Rev Esp Patol."},{"key":"10.1016\/j.patol.2019.08.001_bib0460","first-page":"222","article-title":"Una visi\u00f3n integral del c\u00e1ncer (II). Campos de estudio y biomarcadores emergentes","volume":"52","author":"Noguera","year":"2019","journal-title":"Rev Esp Patol."},{"key":"10.1016\/j.patol.2019.08.001_bib0465","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.aaf2834","article-title":"Cancer Immunology. The \u00abcancer immunogram\u00bb","volume":"352","author":"Blank","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.patol.2019.08.001_bib0470","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2147\/CMAR.S167400","article-title":"Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors","volume":"10","author":"Zhu","year":"2018","journal-title":"Cancer Manag Res."},{"key":"10.1016\/j.patol.2019.08.001_bib0475","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1126\/scitranslmed.aat7807","article-title":"The hallmarks of successful anticancer immunotherapy","volume":"10","author":"Galluzzi","year":"2018","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.patol.2019.08.001_bib0480","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4161\/onci.22009","article-title":"Trial watch: Prognostic and predictive value of the immune infiltrate in cancer","volume":"1","author":"Senovilla","year":"2012","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.patol.2019.08.001_bib0485","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fonc.2013.00107","article-title":"Immune responses to cancer: Are they potential biomarkers of prognosis?","volume":"3","author":"Whiteside","year":"2013","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0490","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.patol.2019.08.001_bib0495","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1200\/JCO.2015.61.6870","article-title":"Pseudoprogression and immune-related response in solid tumors","volume":"33","author":"Chiou","year":"2015","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0500","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41591-018-0094-7","article-title":"Author correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy","volume":"24","author":"Krieg","year":"2018","journal-title":"Nat Med."},{"key":"10.1016\/j.patol.2019.08.001_bib0505","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity."},{"key":"10.1016\/j.patol.2019.08.001_bib0510","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-018-0328-8","article-title":"Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients","volume":"6","author":"Subrahmanyam","year":"2018","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.patol.2019.08.001_bib0515","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: A prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.patol.2019.08.001_bib0520","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the\u2019Immunoscore\u2019 in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J Pathol."},{"key":"10.1016\/j.patol.2019.08.001_bib0525","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/modpathol.2017.156","article-title":"Implications of the tumor immune microenvironment for staging and therapeutics","volume":"31","author":"Taube","year":"2018","journal-title":"Mod Pathol."},{"key":"10.1016\/j.patol.2019.08.001_bib0530","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med."},{"key":"10.1016\/j.patol.2019.08.001_bib0535","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jamaoncol.2016.2450","article-title":"Classification of advanced human cancers based on Tumor Immunity in the MicroEnvironment (TIME) for cancer immunotherapy","volume":"2","author":"Zhang","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0540","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0545","doi-asserted-by":"crossref","first-page":"846872","DOI":"10.1155\/2010\/846872","article-title":"Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes","volume":"2010","author":"Alvaro","year":"2010","journal-title":"J Biomed Biotechnol."},{"key":"10.1016\/j.patol.2019.08.001_bib0550","doi-asserted-by":"crossref","first-page":"e955691","DOI":"10.4161\/21624011.2014.955691","article-title":"Consensus guidelines for the detection of immunogenic cell death","volume":"3","author":"Kepp","year":"2014","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.patol.2019.08.001_bib0555","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell."},{"key":"10.1016\/j.patol.2019.08.001_bib0560","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.patol.2019.08.001_bib0565","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2015.01.006","article-title":"The evolution of checkpoint blockade as a cancer therapy: What's here, what's next?","volume":"33","author":"Shin","year":"2015","journal-title":"Curr Opin Immunol."},{"key":"10.1016\/j.patol.2019.08.001_bib0570","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejca.2017.01.035","article-title":"Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape","volume":"81","author":"Emens","year":"2017","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.patol.2019.08.001_bib0575","doi-asserted-by":"crossref","first-page":"e1468955","DOI":"10.1080\/2162402X.2018.1468955","article-title":"Immunological effects of BRAF+MEK inhibition","volume":"7","author":"Ascierto","year":"2018","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.patol.2019.08.001_bib0580","doi-asserted-by":"crossref","first-page":"e998107","DOI":"10.1080\/2162402X.2014.998107","article-title":"Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model","volume":"4","author":"Du Four","year":"2015","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.patol.2019.08.001_bib0585","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: A clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.patol.2019.08.001_bib0590","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrc.2016.97","article-title":"Engineered T cells: The promise and challenges of cancer immunotherapy","volume":"16","author":"Fesnak","year":"2016","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.patol.2019.08.001_bib0595","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: Moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat Med."},{"key":"10.1016\/j.patol.2019.08.001_bib0600","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","article-title":"Therapeutic vaccines for cancer: An overview of clinical trials","volume":"11","author":"Melero","year":"2014","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0605","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1158\/0008-5472.CAN-11-3001","article-title":"Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: Assessment of safety and immunologic responses in patients","volume":"72","author":"Pesonen","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.patol.2019.08.001_bib0610","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fimmu.2017.00555","article-title":"Oncolytic immunotherapy: Conceptual evolution current strategies, and future perspectives","volume":"8","author":"Guo","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.patol.2019.08.001_bib0615","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yexcr.2010.12.021","article-title":"Chemokines as targets for therapy","volume":"317","author":"Garin","year":"2011","journal-title":"Exper Cell Res."},{"key":"10.1016\/j.patol.2019.08.001_bib0620","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3390\/cancers3043856","article-title":"Cytokines in cancer immunotherapy","volume":"3","author":"Lee","year":"2011","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.patol.2019.08.001_bib0625","first-page":"673","article-title":"Cancer immunotherapy by targeting IDO1\/TDO and their downstream effectors","volume":"5","author":"Platten","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.patol.2019.08.001_bib0630","doi-asserted-by":"crossref","first-page":"e957994","DOI":"10.4161\/21624011.2014.957994","article-title":"Trial watch: IDO inhibitors in cancer therapy","volume":"3","author":"Vacchelli","year":"2014","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.patol.2019.08.001_bib0635","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/annonc\/mdx179","article-title":"Pattern recognition receptors: Immune targets to enhance cancer immunotherapy","volume":"28","author":"Shekarian","year":"2017","journal-title":"Ann Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0640","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2018.03.015","article-title":"SnapShot: CGAS-STING signaling","volume":"173","author":"Galluzzi","year":"2018","journal-title":"Cell."},{"key":"10.1016\/j.patol.2019.08.001_bib0645","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2018.05.013","article-title":"Sensing in organismal tumor control","volume":"34","author":"Vanpouille-Box","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.patol.2019.08.001_bib0650","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-2947","article-title":"Intratumoral injection of the toll-like receptor 4 agonist G100 induces a T-cell response in the soft tissue sarcoma microenvironment","volume":"77","author":"Seo","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.patol.2019.08.001_bib0655","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1078-0432.CCR-18-0469","article-title":"Intratumoral G100, a TLR4 agonist, induces antitumor immune responses and tumor regression in patients with Merkel cell carcinoma","volume":"25","author":"Bhatia","year":"2019","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.patol.2019.08.001_bib0660","unstructured":"Haymaker C. TLR9 agonist harnesses innate immunity to drive tumor-infiltrating T-cell expansion in distant lesions in a Phase 1\/2 study of intratumoral IMO- 2125+ipilimumab in anti-PD1 refractory melanoma patients. Presentado en el Society for Immunotherapy of Cancer Annual Meeting; 2017."},{"key":"10.1016\/j.patol.2019.08.001_bib0665","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","article-title":"Glucocorticoids promote breast cancer metastasis","volume":"567","author":"Obradovi\u0107","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.patol.2019.08.001_bib0670","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tcb.2019.03.005","article-title":"Cancer cells thrive on stress","volume":"29","author":"Galluzzi","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.patol.2019.08.001_bib0675","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fonc.2018.00381","article-title":"EMT and stemness in tumor dormancy and outgrowth: Are they intertwined processes?","volume":"8","author":"Weidenfeld","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12307-019-00222-4","article-title":"Mechanobiology of cancer stem cells and their niche","volume":"12","author":"Roy Choudhury","year":"2019","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.patol.2019.08.001_bib0685","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","article-title":"The cancer stem cell niche: How essential is the niche in regulating stemness of tumor cells?","volume":"16","author":"Plaks","year":"2015","journal-title":"Cell Stem Cell."},{"key":"10.1016\/j.patol.2019.08.001_bib0690","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.1700600114","article-title":"Metabolic origins of spatial organization in the tumor microenvironment","volume":"114","author":"Carmona-Fontaine","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.patol.2019.08.001_bib0695","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","article-title":"Metabolic interactions in the tumor microenvironment","volume":"27","author":"Lyssiotis","year":"2017","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.patol.2019.08.001_bib0700","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.patol.2019.08.001_bib0705","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1242\/jcs.01000","article-title":"The stroma as a crucial target in rat mammary gland carcinogenesis","volume":"117","author":"Maffini","year":"2004","journal-title":"J Cell Sci."},{"key":"10.1016\/j.patol.2019.08.001_bib0710","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2017","journal-title":"Science."},{"key":"10.1016\/j.patol.2019.08.001_bib0715","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"5","author":"Routy","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.patol.2019.08.001_bib0720","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(18)30952-5","article-title":"Modulating the microbiome to improve therapeutic response in cancer","volume":"20","author":"McQuade","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0725","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrmicro.2017.44","article-title":"Anticancer effects of the microbiome and its products","volume":"15","author":"Zitvogel","year":"2017","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.patol.2019.08.001_bib0730","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/806248","article-title":"Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption","author":"Damms-Machado","year":"2015","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.patol.2019.08.001_bib0735","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fonc.2018.00318","article-title":"Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy","volume":"8","author":"Meng","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0740","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fonc.2018.00371","article-title":"Fusobacterium and colorectal cancer","volume":"8","author":"Zhou","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0745","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40425-018-0381-3","article-title":"White paper on microbial anti-cancer therapy and prevention","volume":"6","author":"Forbes","year":"2018","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.patol.2019.08.001_bib0750","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat Med."},{"issue":"Suppl","key":"10.1016\/j.patol.2019.08.001_bib0755","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.bbi.2013.01.003","article-title":"Psychoneuroimmunology and cancer: A decade of discovery, paradigm shifts, and methodological innovations","volume":"30","author":"Green McDonald","year":"2013","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.patol.2019.08.001_bib0760","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1073\/pnas.1512603113","article-title":"Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer","volume":"113","author":"Saloman","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.patol.2019.08.001_bib0765","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1248\/bpb.b15-00128","article-title":"Comparison of the anti-tumor effects of selective serotonin reuptake inhibitors as well as serotonin and norepinephrine reuptake inhibitors in human hepatocellular carcinoma cells","volume":"38","author":"Kuwahara","year":"2015","journal-title":"Biol Pharm Bull."},{"key":"10.1016\/j.patol.2019.08.001_bib0770","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.cellsig.2015.05.008","article-title":"Oncostatic effects of fluoxetine in experimental colon cancer models","volume":"27","author":"Kannen","year":"2015","journal-title":"Cell Signal."},{"key":"10.1016\/j.patol.2019.08.001_bib0775","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3464","article-title":"The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy","volume":"10","author":"Krall","year":"2018","journal-title":"Sci Transl Med."},{"issue":"Suppl","key":"10.1016\/j.patol.2019.08.001_bib0780","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.bbi.2012.03.006","article-title":"Surgery and stress promote cancer metastasis: New outlooks on perioperative mediating mechanisms and immune involvement","volume":"30","author":"Neeman","year":"2013","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.patol.2019.08.001_bib0785","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00262-014-1617-9","article-title":"A nervous tumor microenvironment: The impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response","volume":"63","author":"Eng","year":"2014","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.patol.2019.08.001_bib0790","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science."},{"key":"10.1016\/j.patol.2019.08.001_bib0795","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/onc.2011.576","article-title":"Metabolic reprogramming of the tumor","volume":"31","author":"Ferreira","year":"2012","journal-title":"Oncogene."},{"key":"10.1016\/j.patol.2019.08.001_bib0800","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fcell.2015.00043","article-title":"Cancer as a mitochondrial metabolic disease","volume":"3","author":"Seyfried","year":"2015","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.patol.2019.08.001_bib0805","doi-asserted-by":"crossref","first-page":"e61747","DOI":"10.1371\/journal.pone.0061747","article-title":"Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways","volume":"8","author":"Kaipparettu","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.patol.2019.08.001_bib0810","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fonc.2019.00218","article-title":"Cancer-induced reprogramming of host glucose metabolism: \u00abVicious Cycle\u00bb supporting cancer progression","volume":"9","author":"Schwartsburd","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0815","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37247-6","article-title":"Metformin prevents cell tumorigenesis through autophagy-related cell death","volume":"9","author":"De Santi","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.patol.2019.08.001_bib0820","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3389\/fonc.2018.00436","article-title":"Metformin clinical trial in HPV+ and HPV\u2013 head and neck squamous cell carcinoma: Impact on cancer cell apoptosis and immune infiltrate","volume":"8","author":"Curry","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0825","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fonc.2018.00341","article-title":"Metformin as a therapeutic target in endometrial cancers","volume":"8","author":"Lee","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0830","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13679-017-0263-x","article-title":"Insights into the link between obesity and cancer","volume":"6","author":"Ackerman","year":"2017","journal-title":"Curr Obes Rep."},{"key":"10.1016\/j.patol.2019.08.001_bib0835","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/dom.12124","article-title":"Diabetes and cancer: Two diseases with obesity as a common risk factor","volume":"16","author":"Garg","year":"2014","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.patol.2019.08.001_bib0840","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med."},{"key":"10.1016\/j.patol.2019.08.001_bib0845","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28262","article-title":"Antitumor effects of curcumin: A lipid perspective","author":"Naeini","year":"2019","journal-title":"J Cell Physiol."},{"key":"10.1016\/j.patol.2019.08.001_bib0850","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fmed.2019.00034","article-title":"From big data to precision medicine","volume":"6","author":"Hulsen","year":"2019","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.patol.2019.08.001_bib0855","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-319-67577-0_4","article-title":"The role of tumor microenvironment in cancer immunotherapy","volume":"1036","author":"Frankel","year":"2017","journal-title":"Adv Exp Med Biol."},{"key":"10.1016\/j.patol.2019.08.001_bib0860","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40425-018-0376-0","article-title":"Tumor matrix remodeling and novel immunotherapies: The promise of matrix-derived immune biomarkers","volume":"6","author":"Mushtaq","year":"2018","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.patol.2019.08.001_bib0865","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.patol.2019.08.001_bib0870","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.patol.2019.08.001_bib0875","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fonc.2019.00276","article-title":"Editorial: Cancer plasticity and the microenvironment: Implications for immunity and therapy response","volume":"9","author":"Behren","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.patol.2019.08.001_bib0880","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: Failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int."}],"container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885519300820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885519300820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:06:16Z","timestamp":1761663976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699885519300820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1699885519300820"],"URL":"https:\/\/doi.org\/10.1016\/j.patol.2019.08.001","relation":{},"ISSN":["1699-8855"],"issn-type":[{"type":"print","value":"1699-8855"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Una visi\u00f3n integral del c\u00e1ncer (III). Evaluaci\u00f3n de nuevos biomarcadores y posibilidades de intervenci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Patolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.patol.2019.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Anatom\u00eda Patol\u00f3gica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}